Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension

Pediatric Nephrology

Volumn 15, Issue 1-2, 2000, Pages 113-118

  Soergel, M ^a   Verho, M ^b   Wuhl E ^c   Gellermann, J ^d   Teichert, L ^b   Scharer K ^c  

^a Children's Hospital   (Germany)

^b NONE

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ACE inhibitors; Ambulatory blood pressure; Chronic renal insufficiency; Hypertension; Proteinuria

Indexed keywords

ALBUMIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0033671638     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670000422     Document Type: Article

References (39)

1. ACE inhibitors, AT1 receptor blockers, and the kidney
2. ACE inhibitors: Panacea for progressive renal disease?
3. Efficacy and safety of captopril in the treatment of severe childhood hypertension: Report of the International Collaborative Group
4. Pharmacological treatment of hypertension
5. Evaluation of the efficacy and safety of monotherapy for significant essential hypertension in adolescents with use of enalapril
6. Effect of angiotensin converting enzyme inhibitor therapy on proteinuria in children with renal disease
7. Angiotensin converting enzyme inhibition for reduction of proteinuria in children with steroid-resistant nephrotic syndrome
8. Efficacy of captopril treatment in children with steroid-resistant nephrotic syndrome
9. Long-term therapy with enalapril in patients with nephrotic-range proteinuria
10. Angiotensin converting enzyme inhibitors and reflux nephropathy: A 2 year follow-up
11. Adequate clinical control of congenital nephrotic syndrome by enalapril
12. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus
13. Clinical pharmacokinetics of ramipril
14. Wirksamkeit und vertraglichkeit von ramipril bei 21,257 ambulanten hypertonikern
15. 24-hour blood pressure control with ramipril: Comparison of once-daily morning and evening administration
16. Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man
17. Tight binding of ramiprilat to ACE: Consequences for pharmacokinetic and pharmacodynamic measurements
18. Ambulante blutdruckmessung bei nierentransplantierten kindern und jugendlichen
19. Ambulatory blood pressure monitoring in pediatric patients treated by regular hemodialysis and peritoneal dialysis
20. Temporal blood pressure patterns in children
21. Oscillometric twenty-four hour ambulatory blood pressure values in healthy children and adolescents: A multicenter trial including 1141 subjects
22. Ambulatory monitoring of the blood pressure in multicenter trials
23. Blood pressure in childhood: Pooled findings of six European studies
24. Ambulante blutdruckmessung
25. Proteinuria and enzymuria as leading symptoms of renal and extrarenal diseases in childhood
26. Urinary albumin excretion in school children
27. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents
28. Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria
29. Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
30. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension
31. An investigation of the effect of advancing uremia, renal replacement therapy and renal transplantation on blood pressure diurnal variability
32. Circadian blood pressure variation in transgenic hypertensive rats
33. Prevention of progression of nephropathy
34. Randomized multicenter study of a low protein diet on the progression of chronic renal failure in children
35. Long term benefits of the antiproteinuric effects of angiotensin-converting enzyme inhibition in nondiabetic renal disease
36. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
37. Effect of angiotensin converting enzyme inhibition by perindopril on proteinuria of primary renal disease
38. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency
39. Role of enalapril in the management of nephrotic syndrome